The most plausible explanation for these correlating observations is that CML patients at the time of ID are characterized by more or less severe leucocytosis and display a high proportion of BCR::ABL1 positive peripheral blood cells with high proliferation potential and dysfunctional cell differentiation. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.